Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Acta Academiae Medicinae Sinicae ; (6): 375-377, 2006.
Article in Chinese | WPRIM | ID: wpr-281194

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the distribution and expression of peroxisome proliferator activated receptor gamma (PPAR-gamma) in human pituitary adenomas.</p><p><b>METHODS</b>Thirty eight consecutive surgically resected pituitary adenomas and 5 normal pituitary tissues were enrolled in the study. Immunohistochemistry was used to confirm the distribution of PPAR-gamma. Expression of PPAR-gamma was evaluated by Western blot.</p><p><b>RESULTS</b>PPAR-gamma immunoreactivity was located in the nucleoli of pituitary adenoma cells. PPAR-gamma was expressed in all human pituitary adenomas and normal pituitary tissues. Its expression in pituitary adenomas was significantly higher than in normal pituitary tissues (P < 0.01), and its expression in ACTH-secreting adenomas was significantly higher than in any other type of pituitary adenomas (P < 0.05).</p><p><b>CONCLUSIONS</b>PPAR-gamma may play an important role in the generation, growth, and invasion of human pituitary adenomas. It may become a novel therapeutic target for these tumors.</p>


Subject(s)
Adult , Female , Humans , Male , Middle Aged , ACTH-Secreting Pituitary Adenoma , Metabolism , PPAR gamma , Metabolism , Pituitary Gland , Metabolism , Pituitary Neoplasms , Metabolism
2.
Acta Academiae Medicinae Sinicae ; (6): 415-417, 2006.
Article in Chinese | WPRIM | ID: wpr-281184

ABSTRACT

<p><b>OBJECTIVE</b>To explore factors influencing the recurrence of patients with Cushing's disease after transsphenoidal surgery.</p><p><b>METHODS</b>We retrospectively analyzed the clinical data of 182 patients treated by transsphenoidal surgery with Cushing's disease in our department in PUMC Hospital from 1992 to 2002.</p><p><b>RESULTS</b>The recurrence rates were significantly different when patients had different radiological findings (P = 0.001), operative methods (P = 0.001), histological findings (P = 0.04), and postoperative cortisol levels (P = 0.02); however, such difference was not found in term of tumor size (P = 0.43).</p><p><b>CONCLUSION</b>Radiological findings, operative methods, histological findings, and postoperative cortisol estimates may be the factors influencing the recurrence of patients treated by transsphenoidal surgery.</p>


Subject(s)
Female , Humans , Male , Adenoma , General Surgery , Hypophysectomy , Methods , Pituitary ACTH Hypersecretion , General Surgery , Pituitary Neoplasms , General Surgery , Recurrence , Retrospective Studies
3.
Chinese Medical Sciences Journal ; (4): 23-26, 2005.
Article in English | WPRIM | ID: wpr-305468

ABSTRACT

<p><b>OBJECTIVE</b>To investigate whether somatostatin analog octreotide long acting release (LAR) shrinks growth hormone (GH) secreting adenomas, and improves the results of subsequent transsphenoidal surgery.</p><p><b>METHODS</b>Seventeen previously untreated active acromegalic patients with pituitary adenomas were treated with LAR (30 mg intramuscular injection every 28 days) for 3 months prior to transsphenoidal surgery. Clinical reaction, mean GH secretion, and tumor volume were measured under basal conditions and after LAR treatment.</p><p><b>RESULTS</b>Presurgical treatment improved acromegaly symptoms and induced a significant reduction of GH under the 5 ng/mL limit in microadenoma (P < 0.05), while only 18.2% (2/11) in macroadenoma. Meanwhile, tumor shrinkage occurred in 58.8% (10/17) patients, with 1 case in the microadenoma group. All marked shrinkage (> 25%) occurred in the macroadenoma group. Statistical analysis showed tumor shrinkage caused by LAR was greater in macroadenoma group than that in microadenoma group (P < 0.05). During operation, adenoma was soft in 15 cases, with the exception of 2 cases in which the soft tumor was divided by fibrous septa, but all tumor removal was smooth.</p><p><b>CONCLUSIONS</b>A short term administration of preoperative LAR may induce a significant decrease in GH-secretion level and adenoma volume. Presurgical use of octreotide LAR improves surgical results especially in macroadenomas.</p>


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Acromegaly , Drug Therapy , Adenoma , Drug Therapy , Bodily Secretions , General Surgery , Antineoplastic Agents, Hormonal , Therapeutic Uses , Delayed-Action Preparations , Human Growth Hormone , Bodily Secretions , Hypophysectomy , Methods , Octreotide , Therapeutic Uses , Pituitary Neoplasms , Drug Therapy , Bodily Secretions , General Surgery , Preoperative Care
4.
Chinese Medical Sciences Journal ; (4): 198-201, 2005.
Article in English | WPRIM | ID: wpr-305423

ABSTRACT

<p><b>OBJECTIVE</b>To introduce a new principle of sellar reconstruction and to evaluate the effectiveness of absorbable gelatin foam and fibrin glue for sellar reconstruction.</p><p><b>METHODS</b>A total of 176 consecutive patients who underwent surgery for pituitary adenomas, cysts, chordomas, or subdiaphragmatic craniopharyngiomas in the sella turcica between January 2001 and April 2003 at Peking Union Medical College Hospital were enrolled. Different techniques of sellar closure and indications for each specific condition were retrospectively reviewed.</p><p><b>RESULTS</b>Seventy-seven (43.7%) patients developed a visible cerebrospinal fluid (CSF) leakage during surgery. Intra-operative CSF leakage were repaired simply with gelatin foam and fibrin glue in 62 (35.2%) patients, and with autologous fat graft and sellar floor reconstruction in 15 (8.5%) patients. Postoperative CSF rhinorrhea occurred only in 1 case. There were no visual deterioration, allergic rhinitis, meningitis, pneumocranium, granulomas, or other complications associated with the reconstruction procedure.</p><p><b>CONCLUSION</b>The procedure of using gelatin foam and fibrin glue and principle of cranial base reconstruction is safe and effective in preventing postoperative complications following transsphenoidal surgery.</p>


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Adenoma , General Surgery , Central Nervous System Cysts , General Surgery , Cerebrospinal Fluid Rhinorrhea , General Surgery , Craniopharyngioma , General Surgery , Fibrin Tissue Adhesive , Therapeutic Uses , Follow-Up Studies , Gelatin Sponge, Absorbable , Therapeutic Uses , Hypophysectomy , Methods , Pituitary Neoplasms , General Surgery , Plastic Surgery Procedures , Methods , Retrospective Studies , Sella Turcica , General Surgery , Tissue Adhesives , Therapeutic Uses
SELECTION OF CITATIONS
SEARCH DETAIL